CONTEXT: Transcription factor steroidogenic factor-1 (SF-1) plays a pivotal role in the control of adrenocortical cell steroidogenesis and proliferation. SF-1 amplification and overexpression are found in most cases of childhood adrenocortical tumors (ACTs). OBJECTIVE: Our objective was to investigate the effect of SF-1 inverse agonists of the alkyloxyphenol and isoquinolinone classes on the proliferation of human adrenocortical cell lines expressing SF-1 (H295R), in conditions of basal and increased SF-1 expression, or negative for SF-1 expression (SW-13). MAIN OUTCOME MEASURES: Proliferation assays, immunoblots, flow cytometric analyses, steroid hormone assays, and reverse transcription quantitative PCR were used. RESULTS: SF-1 inhibitors of the alkyloxyphenol class displayed a dose-dependent inhibitory effect on both SF-1-positive and -negative ACT cells, whereas SF-1 inverse agonists of the isoquinolinone class selectively inhibited cell proliferation elicited by SF-1 overexpression. These drugs also inhibited stimulated steroid hormone secretion and CYP21 and CYP17 mRNA expression. CONCLUSION: SF-1 inhibitors may represent a useful tool in the chemotherapy of ACTs.
CONTEXT: Transcription factor steroidogenic factor-1 (SF-1) plays a pivotal role in the control of adrenocortical cell steroidogenesis and proliferation. SF-1 amplification and overexpression are found in most cases of childhood adrenocortical tumors (ACTs). OBJECTIVE: Our objective was to investigate the effect of SF-1 inverse agonists of the alkyloxyphenol and isoquinolinone classes on the proliferation of humanadrenocortical cell lines expressing SF-1 (H295R), in conditions of basal and increased SF-1 expression, or negative for SF-1 expression (SW-13). MAIN OUTCOME MEASURES: Proliferation assays, immunoblots, flow cytometric analyses, steroid hormone assays, and reverse transcription quantitative PCR were used. RESULTS:SF-1 inhibitors of the alkyloxyphenol class displayed a dose-dependent inhibitory effect on both SF-1-positive and -negative ACT cells, whereas SF-1 inverse agonists of the isoquinolinone class selectively inhibited cell proliferation elicited by SF-1 overexpression. These drugs also inhibited stimulated steroid hormone secretion and CYP21 and CYP17 mRNA expression. CONCLUSION:SF-1 inhibitors may represent a useful tool in the chemotherapy of ACTs.
Authors: Mara A D Pianovski; Luciane R Cavalli; Bonald C Figueiredo; Savana C L Santos; Mabrouka Doghman; Raul C Ribeiro; Antonio G Oliveira; Edson Michalkiewicz; Giovanna A Rodrigues; Gerard Zambetti; Bassem R Haddad; Enzo Lalli Journal: Eur J Cancer Date: 2006-03-29 Impact factor: 9.162
Authors: Y Sadovsky; P A Crawford; K G Woodson; J A Polish; M A Clements; L M Tourtellotte; K Simburger; J Milbrandt Journal: Proc Natl Acad Sci U S A Date: 1995-11-21 Impact factor: 11.205
Authors: Ferdous M Barlaskar; Aaron C Spalding; Joanne H Heaton; Rork Kuick; Alex C Kim; Dafydd G Thomas; Thomas J Giordano; Edgar Ben-Josef; Gary D Hammer Journal: J Clin Endocrinol Metab Date: 2008-10-14 Impact factor: 5.958
Authors: Franck Madoux; Xiaolin Li; Peter Chase; Gina Zastrow; Michael D Cameron; Juliana J Conkright; Patrick R Griffin; Scott Thacher; Peter Hodder Journal: Mol Pharmacol Date: 2008-03-11 Impact factor: 4.436
Authors: Andria L Del Tredici; Carsten B Andersen; Erika A Currier; Steven R Ohrmund; Luke C Fairbain; Birgitte W Lund; Norman Nash; Roger Olsson; Fabrice Piu Journal: Mol Pharmacol Date: 2007-11-30 Impact factor: 4.436
Authors: Maria Alexiadis; Natalie Eriksson; Stacey Jamieson; Melissa Davis; Ann E Drummond; Simon Chu; Colin D Clyne; George E Muscat; Peter J Fuller Journal: Horm Cancer Date: 2011-06 Impact factor: 3.869
Authors: Yasmin M Vasquez; San-Pin Wu; Matthew L Anderson; Shannon M Hawkins; Chad J Creighton; Madhumita Ray; Sophia Y Tsai; Ming-Jer Tsai; John P Lydon; Francesco J DeMayo Journal: Mol Endocrinol Date: 2016-03-28